TD Waterhouse Canada’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Sell
19
-3,114
-99% -$2.12M ﹤0.01% 1785
2026
Q1
$2.44M Sell
3,133
-3,723
-54% -$2.85M 0.01% 519
2025
Q4
$5.29M Sell
6,856
-2,340
-25% -$1.59M 0.03% 274
2025
Q3
$5.51M Buy
9,196
+4,583
+99% +$2.59M 0.04% 261
2025
Q2
$2.47M Buy
4,613
+4,586
+16,985% +$2.56M 0.02% 397
2025
Q1
$16.6K Sell
27
-26
-49% -$17.9K ﹤0.01% 1299
2024
Q4
$37.8K Sell
53
-4,240
-99% -$3.56M ﹤0.01% 1147
2024
Q3
$4.49M Sell
4,293
-413
-9% -$460K 0.04% 275
2024
Q2
$4.97M Sell
4,706
-103
-2% -$99.8K 0.04% 242
2024
Q1
$4.69M Buy
4,809
+881
+22% +$838K 0.04% 259
2023
Q4
$3.7M Sell
3,928
-670
-15% -$552K 0.03% 249
2023
Q3
$4.62M Buy
4,598
+2,709
+143% +$2.13M 0.05% 204
2023
Q2
$1.38M Buy
1,889
+75
+4% +$57.8K 0.01% 373
2023
Q1
$1.52M Sell
1,814
-81
-4% -$61.1K 0.02% 353
2022
Q4
$1.39M Sell
1,895
-363
-16% -$268K 0.02% 357
2022
Q3
$1.74M Buy
2,258
+544
+32% +$342K 0.02% 323
2022
Q2
$1.02M Buy
1,714
+57
+3% +$37.1K 0.01% 408
2022
Q1
$1.15M Buy
1,657
+104
+7% +$65.8K 0.01% 424
2021
Q4
$961K Buy
+1,553
New +$955K 0.01% 492

Other funds holding REGN

TD Waterhouse Canada's REGN Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Regeneron Pharmaceuticals (REGN) stake by 99% in Q2 2026, selling an estimated $2.12M and leaving 19 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

TD Waterhouse Canada first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.51M in Q3 2025. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • TD Waterhouse Canada held 19 shares of Regeneron Pharmaceuticals worth $11.9K as of Q2 2026.
  • TD Waterhouse Canada sold 3,114 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.12M.
  • Regeneron Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1785 holding.
  • TD Waterhouse Canada first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Regeneron Pharmaceuticals position peaked at $5.51M in Q3 2025.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.